Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
IOL Chemicals & Pharmaceuticals Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Expansion plans supported by capex of INR 200-250 crores annually, with 60% towards expansion/new products and 40% towards efficiency improvements. Key concall…
11 Sept 2026
Happiest Minds Technologies Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Geographic balance (38% Americas, 31% Europe, 31% rest of world) and sector diversification support stable growth (Page 11). Key concall takeaways from…
10 Sept 2026
Sapphire Foods India Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Overall, consolidated revenue grew 15% in Q1 FY ‘27, the best in 11 quarters, with 37% adjusted EBITDA growth. Key concall takeaways from Sapphire Foods India…
10 Sept 2026
Ujjivan Small Finance Bank Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Loan book growth recorded approximately 29% year-on-year in Q1, indicating strong momentum. Key concall takeaways from Ujjivan Small Finance Bank Ltd's Q1 FY27…
10 Sept 2026
Mitsu Chem Plast Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Q1 FY27 showed strong profitability with EBITDA margin improving to 16.29% and net profit margin to 9.18%. Key concall takeaways from Mitsu Chem Plast Ltd's Q1…
10 Sept 2026
Sterlite Technologies Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
The company plans to invest approximately ₹1,000 crores annually over the next 3 years to expand preform fiber and cable capacities by 50%. Key concall…
10 Sept 2026
Ardee Industries Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Capacity expansion increased installed capacity by 50.9% to 1,56,950 MTPA as of May 2026, enabling future growth opportunities. Key concall takeaways from…
10 Sept 2026
Nexus Select Trust Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Consumption growth was robust at 17% year-on-year in Q1 FY27, with positive momentum continuing into July. Key concall takeaways from Nexus Select Trust's Q1…
9 Sept 2026
Sonata Software Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
AI order book contributes 18.2% to the overall order book. Key concall takeaways from Sonata Software Ltd's Q1 FY27 earnings call — and how it ranks against…
9 Sept 2026
Innova Captab Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
The company is confident of achieving 20%+ volume growth backed by steady ramp-up in Jammu and existing facilities. Key concall takeaways from Innova Captab…
9 Sept 2026
Pakka Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Neo Asset Management invested ₹30 crore in equity, and promoters’ shares are pledged as security. Key concall takeaways from Pakka Ltd's Q1 FY27 earnings call…
9 Sept 2026
Xtranet Technologies Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
500+ crores, up from Rs. Key concall takeaways from Xtranet Technologies Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
9 Sept 2026
Exim Routes Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
207 crores, up 72% YoY, driven mainly by volume expansion. Key concall takeaways from Exim Routes Ltd's Q4 FY26 earnings call — and how it ranks against sector…
9 Sept 2026
Indo Borax & Chemicals Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
9 Sept 2026
NATIONALUM Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Smelter expansion capex planned around INR4,000-5,000 crores per annum starting FY28, peaking in FY29-FY31. Key concall takeaways from NATIONALUM's Q1 FY27…
8 Sept 2026
Glenmark Pharma. Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Chronic respiratory segment in India showing over 25% growth; oncology and cardiovascular segments also strong. Key concall takeaways from Glenmark Pharma.'s…
8 Sept 2026
STAR Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
markets continue to be broad-based growth drivers, with 17% YoY growth and expansion in B2B and B2C markets including Europe, UK, Nordics, Africa, LATAM, MENA…
8 Sept 2026
Techno Electric & Engineering Company Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Revenue grew by 25% this quarter; order inflow momentum is strong with an order book around INR11,000 crores, providing good visibility. Key concall takeaways…
8 Sept 2026
SPR Auto Technologies Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Emerging segments such as EV motors, drone motors, and electric marine motors through the EMFi subsidiary show scalable growth potential, with peak sales…
8 Sept 2026
ADANIPORTS Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Logistics volumes showed a 19% decline in Q1 but have stabilized and are recovering moderately. Key concall takeaways from ADANIPORTS's Q1 FY27 earnings call…
8 Sept 2026